GlaxoSmithKline: all 4,196 studies
Page 15 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean FemalesCompletedNCT01101542Results posted
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.CompletedNCT01098539Phase 3Results posted
- Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) DrugsCompletedNCT01098500Results posted
- A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT01098487Phase 4Results posted
- Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy InfantsCompletedNCT01098474Phase 2Results posted
- Dose Ranging Study of Albiglutide in Japanese SubjectsCompletedNCT01098461Phase 2Results posted
- A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological AssaysCompletedNCT01098006Not applicableResults posted
- Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy ChildrenCompletedNCT01096056Phase 1Results posted
- Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in RussiaCompletedNCT01094171Phase 4Results posted
- Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy InfantsCompletedNCT01090453Phase 2Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ VaccineCompletedNCT01086423Phase 3Results posted
- Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) AxisCompletedNCT01086410Phase 3Results posted
- Asthma Exacerbation StudyCompletedNCT01086384Phase 3Results posted
- Post-operative Dental Pain Study Comparing Analgesic EfficacyCompletedNCT01082081Phase 4Results posted
- A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic LeukemiaCompletedNCT01077622Phase 2Results posted
- Carcinogenicity Study of BupropionCompletedNCT01077596Results posted
- Dose Response of a Tubule Occlusion AgentCompletedNCT01075256Phase 4Results posted
- Post-operative Dental Pain Study Comparing Two Different Dosage of Analgesic EfficacyCompletedNCT01075243Phase 4Results posted
- A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to PlaceboCompletedNCT01072149Phase 3Results posted
- Hemorrhage Risk Prescribed ArixtraCompletedNCT01064362Results posted
- Lamotrigine Pregnancy Registry (LAM05)CompletedNCT01064297Results posted
- Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in AdultsCompletedNCT01059617Phase 1Results posted
- Fracture Risk With ThiazolidinedionesCompletedNCT01055223Results posted
- Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01054885Phase 3Results posted
- Fosamprenavir in Pts With Hepatic ImpairmentCompletedNCT01054586Results posted
- A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01053988Phase 3Results posted
- Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of AgeCompletedNCT01051661Phase 3Results posted
- Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction ChemotherapyCompletedNCT01051063Phase 1Results posted
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPDCompletedNCT01039675Phase 2Results posted
- Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF InhibitorCompletedNCT01037127Phase 2Results posted
- Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix AdultCompletedNCT01037114Phase 4Results posted
- Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative ColitisCompletedNCT01036022Phase 2Results posted
- Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 YearsCompletedNCT01035749Phase 2Results posted
- Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected FemalesCompletedNCT01031069Phase 4Results posted
- 28-day Repeat Dose Study of GSK573719CompletedNCT01030965Phase 2Results posted
- Booster and Catch-up Vaccination With Vaccine GSK1024850ACompletedNCT01030822Phase 3Results posted
- Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese ChildrenCompletedNCT01027845Phase 3Results posted
- A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature EjaculationCompletedNCT01021553Phase 2Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ VaccineCompletedNCT01021293Phase 3Results posted
- Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety StudyCompletedNCT01018186Phase 3Results posted
- Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute RhinosinusitisCompletedNCT01018030Phase 2Results posted
- A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01017952Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301CompletedNCT01017146Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial AcneCompletedNCT01017120Phase 3Results posted
- A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne VulgarisCompletedNCT01016977Phase 4Results posted
- Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical MedicationsCompletedNCT01015638Phase 4Results posted
- Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in HospitalCompletedNCT01014988Phase 2Results posted
- Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell LymphomaCompletedNCT01014208Phase 3Results posted
- Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in ChildrenTerminatedNCT01014091Phase 3Results posted
- Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1CompletedNCT01009814Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01009463Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of GSK239512 in SchizophreniaCompletedNCT01009060Phase 2Results posted
- In Situ Caries Model of Fluoride ToothpastesCompletedNCT01005966Phase 3Results posted
- Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous ThromboembolismCompletedNCT01004939Results posted
- Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in ChildrenTerminatedNCT01003418Phase 2Results posted
- Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese ChildrenCompletedNCT01001169Phase 2Results posted
- Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy InfantsCompletedNCT01000974Phase 3Results posted
- The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 TrialCompletedNCT01000727Phase 3Results posted
- Dose Ranging Efficacy And Safety With Mepolizumab in Severe AsthmaCompletedNCT01000506Phase 2Results posted
- Orvepitant (GW823296) in Adult Post Traumatic Stress DisorderCompletedNCT01000493Phase 2Results posted
- Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix AdultCompletedNCT01000324Phase 4Results posted
- Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's LymphomaCompletedNCT00996996Phase 2Results posted
- Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)TerminatedNCT00996944Phase 2Results posted
- SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDSCompletedNCT00996840Phase 2Results posted
- Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received RituximabCompletedNCT00996593Phase 2Results posted
- Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390CompletedNCT00996216Phase 3Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female SubjectsCompletedNCT00996125Phase 3Results posted
- Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell LymphomaCompletedNCT00992992Phase 2Results posted
- Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly PeopleCompletedNCT00992784Phase 3Results posted
- Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing ProcessesCompletedNCT00992511Phase 3Results posted
- Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's LymphomaCompletedNCT00989664Phase 2Results posted
- Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)CompletedNCT00989612Phase 2Results posted
- Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in AdultsCompletedNCT00989287Phase 3Results posted
- Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking CessationCompletedNCT00985985Phase 3Results posted
- Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy ChildrenCompletedNCT00985790Phase 2Results posted
- Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First VaccinationCompletedNCT00985751Phase 2Results posted
- Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in AdultsCompletedNCT00985673Phase 2Results posted
- Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in MaliCompletedNCT00985465Phase 3Results posted
- Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and OlderCompletedNCT00985088Phase 2Results posted
- Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00984659Phase 4Results posted
- Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B VaccinationCompletedNCT00984139Phase 4Results posted
- The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedNCT00981409Phase 3Results posted
- Efficacy and Safety Study in Subjects With AsthmaCompletedNCT00980200Phase 2Results posted
- Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in ChildrenCompletedNCT00980005Phase 3Results posted
- Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and OlderCompletedNCT00979602Phase 3Results posted
- Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)CompletedNCT00979407Phase 3Results posted
- Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of AgeCompletedNCT00976820Phase 2Results posted
- Clinical Study to Test a New Drug to Treat Major DepressionCompletedNCT00976560Phase 2Results posted
- A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineCompletedNCT00976391Phase 3Results posted
- Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in AdultsCompletedNCT00975884Phase 3Results posted
- Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612CompletedNCT00974363Phase 3Results posted
- Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine DoseCompletedNCT00972725Phase 2Results posted
- Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in ChildrenCompletedNCT00972517Phase 3Results posted
- 723/726 Proof of Concept Study in Allergen Challenge Chamber in HannoverCompletedNCT00972504Phase 2Results posted
- Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)CompletedNCT00971425Phase 3Results posted
- Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)CompletedNCT00971321Phase 2Results posted
- Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of AgeCompletedNCT00970307Phase 2Results posted
- Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMCompletedNCT00969436Phase 3Results posted
- Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean InfantsCompletedNCT00969228Phase 4Results posted
- Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in ElderlyCompletedNCT00968890Phase 2Results posted